Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

NETWORK 5NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Gynecologic 1

Conditions

Lymphoma 14Sarcoma 13Lymphoma, Large B-Cell, Diffuse 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lung Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Liposarcoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Fibrosarcoma 5Neuroblastoma 4Hodgkin Disease 4Hemangiosarcoma 4Carcinoma, Non-Small-Cell Lung 4Testicular Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malignant mesenchymal tumor 3Leukemia, Myeloid, Acute 3Hemangiopericytoma, Malignant 3Dendritic Cell Sarcoma, Interdigitating 3Central Nervous System Neoplasms 3Blast Crisis 3

Interventions

Radiotherapy 3Ifosfamide 3Doxorubicin 3Vincristine 2Neoadjuvant Therapy 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Carboplatin 2romidepsin 1cixutumumab 1Temozolomide 1Sorafenib 1Peripheral Blood Stem Cell Transplantation 1Molecular Diagnostic Techniques 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Filgrastim 1Brachytherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Hemangiopericytoma, Malignant × Ifosfamide × Clear all
NCT00002898 2013-12-04

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡